Showing results (91-100 of 223) with videos related to
Sort By:
Pageof 23
Investigational New Drugs|June 6, 2009
Reversible cardiogenic shock following 5-fluorouracil infusionCharles Ferté, Carlos Gomez Roca, Yohann Loriot, et al.Lung Cancer (Amsterdam, Netherlands)|December 19, 2008
Telomere length, telomeric proteins and DNA damage repair proteins are differentially expressed between primary lung tumors and their adrenal metastasesChristophe M Raynaud, Olaf Mercier, Frederic Commo, et al.Anticancer Research|January 29, 2011
Pharmacogenetic tailoring of irinotecan-based first-line chemotherapy in metastatic colorectal cancer: results of a pilot studyGilles Freyer, Aude Duret, Gerard Milano, et al.JAMA Network Open|December 21, 2021
Assessment of Treatment Effects and Long-term Benefits in Immune Checkpoint Inhibitor Trials Using the Flexible Parametric Cure Model: A Systematic ReviewThomas Filleron, Marine Bachelier, Julien Mazieres, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2011
Population analysis of erlotinib in adults and children reveals pharmacokinetic characteristics as the main factor explaining tolerance particularities in childrenMelanie White-Koning, Elodie Civade, Birgit Geoerger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2010
Preclinical and clinical evidence that Deoxy-2-[18F]fluoro-D-glucose positron emission tomography with computed tomography is a reliable tool for the detection of early molecular responses to erlotinib in head and neck cancerSébastien Vergez, Jean-Pierre Delord, Fabienne Thomas, et al.Journal for Immunotherapy of Cancer|November 16, 2019
Anti-TNF, a magic bullet in cancer immunotherapy?Anne Montfort, Carine Dufau, Céline Colacios, et al.European Journal of Cancer (Oxford, England : 1990)|June 16, 2009
Population pharmacokinetics of erlotinib and its pharmacokinetic/pharmacodynamic relationships in head and neck squamous cell carcinomaFabienne Thomas, Philippe Rochaix, Melanie White-Koning, et al.Cancer Letters|July 25, 2012
Ovarian ascites-derived Hospicells promote angiogenesis via activation of macrophagesMagali Castells, Benoît Thibault, Eliane Mery, et al.Frontiers in Medicine|August 14, 2024
A double-edged sword: unusual multiple severe infections with pralsetinib: a case report and literature reviewFrançois Poumeaud, Marion Jaffrelot, Carlos Gomez-Roca, et al.Pageof 23